ALOHA VANILLA PREMIUM PROTEIN is a powder and product is packed as the following: 1) Tin:
Recalling firm: Aloha
Why it was recalled
Aloha has recalled protein powder dietary supplements due to the presence of Staphylococcus enterotoxin
Check your package
Compare the exact product and package details with the label you have.
ProductALOHA VANILLA PREMIUM PROTEIN is a powder and product is packed as the following: 1) Tin: UPC 641061842606, 2) Pouch: UPC 641061842644 and 3) Protein Tower 14 pack: UPC 640864820729. Formulated, Quality Tested & Exclusively Sold by ALOHA, Inc. NY, NY 10011 +1 888.444.3898
UPC640864820729, 641061842606, 641061842644
FDA code information
All lot codes (GI-6940, GI-6967, GI-7009, GI-7039)
Match the product, package size, and code together. A missing match does not guarantee safety.
Full FDA record and distribution details
Original product description
ALOHA VANILLA PREMIUM PROTEIN is a powder and product is packed as the following: 1) Tin: UPC 641061842606, 2) Pouch: UPC 641061842644 and 3) Protein Tower 14 pack: UPC 640864820729. Formulated, Quality Tested & Exclusively Sold by ALOHA, Inc. NY, NY 10011 +1 888.444.3898
Extracted codes and context
| Type | Code / value | Context |
|---|---|---|
| UPC | 640864820729 | UPC 641061842606, 2) Pouch: UPC 641061842644 and 3) Protein Tower 14 pack: UPC 640864820729. Formulated, Quality Tested & Exclusively Sold by ALOHA, Inc. NY, NY 10011 +1 888.444.3898 |
| UPC | 641061842606 | PREMIUM PROTEIN is a powder and product is packed as the following: 1) Tin: UPC 641061842606, 2) Pouch: UPC 641061842644 and 3) Protein Tower 14 pack: UPC 640864820729. Formulated, Quality Tested & Exclusively S |
| UPC | 641061842644 | and product is packed as the following: 1) Tin: UPC 641061842606, 2) Pouch: UPC 641061842644 and 3) Protein Tower 14 pack: UPC 640864820729. Formulated, Quality Tested & Exclusively Sold by ALOHA, Inc. NY, NY 10 |
Recall details
- Recall number
- F-1587-2015
- Event ID
- 70398
- FDA status
- Terminated
- Initiated
- Jan 29, 2015
- Reported
- Apr 1, 2015
- Classified
- Mar 24, 2015
- Terminated
- May 3, 2017
- Quantity
- 58,146 units
- Location
- New York, NY, United States
- Initiation type
- Voluntary: Firm initiated
- Notification
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Where it was distributed
nationwide via internet sales and in NY via 6 retail stores.
FDA source record · F-1587-2015
Data updated September 16, 2026. View official FDA data ↗
Follow official FDA and manufacturer guidance.